Torsade de pointes associated with low-dose amisulpride: a case report

Abstract

Get full access to this article

View all access options for this article.

References

Agelink, MW , Majewski, T. , Wurthmann, C. , Lukas, K. , Ullrich, H. , Linka, T. , et al. (2001) Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole and clozapine. J Clin Psychopharmacol 21: 8-13.

American Psychiatric Association (2004) Practice Guidelines for the Treatment of Patients with Schizophrenia, second ed. http://www.psychiatryonline.com/pracGuide/pracGuideTopic_6.aspx (accessed 22.03.08).

De Bruin, ML , Pettersson, M. , Meyboom, RHB , Hoes, AW , Leufkens, HGM ( 2005) Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 26: 590-597.

European Medicines Agency (2005) Committee for Proprietary Medicinal Products. The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals. Note for Guidance on the Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals. http://www.emea.europa.eu/pdfs/human/ich/042302en.pdf (accessed 22.03.08).

Gil, FP , Grohmann, R. , Ruther, E. ( 2001) Asymptomatic bradycardia associated with amisulpride . Pharmacopsychiatry 34: 259-261.

Gupta, A. , Lawrence, AT , Krishnan, K. , Kavinsky, CJ , Trohman, RG ( 2007) Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 153: 891-899.

Isbister, GK , Murray, L. , John, S. , Hackett, LP , Haider, T. , O’Mullane, P. , et al. (2006) Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsade de pointes. Med J Aust 184: 354-356.

Kongsamut, S. , Kang, J. , Chen, XL , Roehr, J. , Rampe, D. ( 2002) A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur J Pharm 450: 37-41.

Lynch, MJ , Woods, J. , George, N. , Gerostamoulos, D. ( 2008) Fatality due to amisulpride toxicity: a case report . Med Sci Law 48: 173- 177.

10.

Mago, R. ( 2004) Searching the medical literature for case reports . J Clin Psychiatry 65: 444-445.

11.

Naranjo, CA , Busto, U. , Sellers, EM , Sandor, P. , Ruiz, I. , Roberts, EA , et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245.

12.

National Institute of Clinical Excellence ( 2002) Guidance on the Use of Newer (atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. http://www.nice.org.uk/guidance/index.jsp?action=download&o=32378 (accessed 22.03.08).

13.

Sanofi-Aventis (2007) Solian (Amisulpride) Product Insert: Sanofi-Aventis. Hong Kong Limited.

14.

Titier, K. , Canal, M. , Deridet, E. , Abouelfath, A. , Gromb, S. , Molimard, M. , et al. (2004) Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol 199: 52-60.

15.

Titier, K. , Girodet, P. , Verdoux, H. , Molimard, M. , Begaud, B. , Haverkamp, W. , et al. (2005) Atypical antipsychotics from potassium channels to torsade de pointes and sudden death. Drug Saf 28: 35-51.

16.

Tracqui, A. , Mutter-Schmidt, C. , Kintz, P. , Berton, C. , Mangin, P. ( 1995) Amisulpride poisoning: a report of two cases. Hum Exp Toxicol 14: 294-298.

17.

Ward, DI ( 2005) Two cases of amisulpride overdose: a cause for prolonged QT syndrome. Emerg Med Australas 17: 274-276.